- Home
- PFAI vs TPST Comparison
PFAI vs TPST Comparison
Compare PFAI & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFAI
- TPST
- Stock Information
- Founded
- PFAI 2015
- TPST 2011
- Country
- PFAI Canada
- TPST United States
- Employees
- PFAI N/A
- TPST N/A
- Industry
- PFAI Farming/Seeds/Milling
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- PFAI Consumer Staples
- TPST Health Care
- Exchange
- PFAI Nasdaq
- TPST Nasdaq
- Market Cap
- PFAI 21.1M
- TPST 33.0M
- IPO Year
- PFAI 2025
- TPST N/A
- Fundamental
- Price
- PFAI $1.85
- TPST $7.80
- Analyst Decision
- PFAI
- TPST Hold
- Analyst Count
- PFAI 0
- TPST 3
- Target Price
- PFAI N/A
- TPST $30.00
- AVG Volume (30 Days)
- PFAI 239.8K
- TPST 94.5K
- Earning Date
- PFAI 01-01-0001
- TPST 08-07-2025
- Dividend Yield
- PFAI N/A
- TPST N/A
- EPS Growth
- PFAI N/A
- TPST N/A
- EPS
- PFAI 0.03
- TPST N/A
- Revenue
- PFAI $3,289,862.00
- TPST N/A
- Revenue This Year
- PFAI N/A
- TPST N/A
- Revenue Next Year
- PFAI N/A
- TPST N/A
- P/E Ratio
- PFAI $62.00
- TPST N/A
- Revenue Growth
- PFAI 56.60
- TPST N/A
- 52 Week Low
- PFAI $1.55
- TPST $5.35
- 52 Week High
- PFAI $4.40
- TPST $28.34
- Technical
- Relative Strength Index (RSI)
- PFAI N/A
- TPST 59.30
- Support Level
- PFAI N/A
- TPST $7.13
- Resistance Level
- PFAI N/A
- TPST $8.75
- Average True Range (ATR)
- PFAI 0.00
- TPST 0.45
- MACD
- PFAI 0.00
- TPST 0.13
- Stochastic Oscillator
- PFAI 0.00
- TPST 63.83
About PFAI Pinnacle Food Group Limited Class A Common Shares
Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware, and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups, and is developing a hydroponic growing system for urban farms. Geographically, the company generates the majority revenue from Canada, followed by New Zealand.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.